{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:28:24Z","timestamp":1771342104605,"version":"3.50.1"},"reference-count":68,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1080\/14740338.2021.1857723","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T08:11:50Z","timestamp":1606551110000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Safety of current treatments for paroxysmal nocturnal hemoglobinuria"],"prefix":"10.1080","volume":"20","author":[{"given":"Sung-Eun","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Wook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-522128"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60584-2"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.208"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1653"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.177618"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511093331904"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1346-4"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24278"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.2.214"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.093161"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01195.x"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.062828"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13176"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095646"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21757"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08096.x"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-333997"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061648"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031688"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094136"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195909"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018020644"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01157"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1177\/2040620719874728"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1344"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12347"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15790"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.236877"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-560540"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b15-00703"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-760496"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-732800"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311084"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1177\/2040620716681748"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0564"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.209692"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781450"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002497"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127005"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-1995-1"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502950"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.11.003"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25068"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318258079a"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24070"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1725468"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876136"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876805"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-128746"},{"key":"cit0050","doi-asserted-by":"crossref","unstructured":"Schrezenmeier H, Mitchell L, Sicre de Fontbrune F, et al. One-year efficacy of ravulizumab (ALXN1210) in adult patients with paroxysmal nocturnal hemoglobinuria na\u00efve to complement inhibitors. European Hematology Association Abstract. 2019:S863.","DOI":"10.1097\/01.HS9.0000561732.59725.64"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.007229"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-189944"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2016.09.002"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-398792"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.07.014"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017848"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-625871"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1005108"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-151613"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2014.953926"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.06.001"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.04.011"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.090001"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00401-1"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25016"},{"key":"cit0066","doi-asserted-by":"crossref","unstructured":"Browett P, Lee JW, Notaro R, et al. A phase 2 open-label proof of concept study of the oral, small molecule factor D inhibitor, ACH-4471, in untreated patients with paroxysmal nocturnal hemoglobinuria (PNH). European Hematology Association Abstract. 2019:S864.","DOI":"10.1097\/01.HS9.0000561736.36854.4e"},{"key":"cit0067","doi-asserted-by":"crossref","unstructured":"Hillmen P, Weitz I, R\u00f6th A, et al. Results of the pegasus phase III randomized trial demonstrating superiority of the C3 inhibitor, pegcetacoplan, compared to eculizumab in patients with paroxysmal nocturnal hemoglobinuria. European Hematology Association Abstract. 2020;S192.","DOI":"10.1016\/j.htct.2020.10.021"},{"key":"cit0068","unstructured":"Kulasekararaj AG, Glasmacher A, Liu P, et al. Development of a composite endpoint to evaluate treatment benefit in patients with paroxysmal nocturnal hemoglobinuria. European Hematology Association Abstract. 2020:EP845."}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2021.1857723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T04:52:56Z","timestamp":1620449576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2021.1857723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"alternative-id":["10.1080\/14740338.2021.1857723"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2021.1857723","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}